Apply now to the #DriveLifeSciences Spring 2026 cohort for emerging biotech and biomarker/diagnostic companies! @MassBio and @SCBiotech are seeking applicants for the Spring program. Learn more & apply by 1/16 https://t.co/7L7tZHAetI

“My dream is that one day no kid has to suffer from a disease that can be cured. Patient advocacy means standing up even when you’re small. Love can change science, and families can change the world.” Read more in our recent blog:

"Through uncertainty and optimism alike, MassBio has remained your constant partner, amplifying your voice on Beacon Hill and in Washington, and strengthening the infrastructure that supports innovation." Read more from our CEO & President @KendalleOC

The CEO & Founder Link is going to San Francisco! Our next events will be during the J.P Morgan Healthcare Conference in January. Life sciences company CEOs or founders: Apply to join - https://t.co/WkGupfR7Hl Current Link Members: Check your inbox for your invite!

Every year, #StateofPossible26 brings together the highest caliber of industry leaders into one room, and this year is shaping up to be no different. Registration is open: https://t.co/ByrnqzkRjh *New in 2026* - #MassBioMembers Early-Bird Offer Promotion Code: EBSOP26

The new paradigm for drug discovery has dramatically accelerated—AI can design molecules in weeks. So why haven’t we seen an impact in the number of drugs in development or approved? Dash Bio's CEO, tackles this in a recent blog:

The MassBio team will be in San Francisco the week of January 11, 2026, during the J.P. Morgan Healthcare Conference. Be sure to reach out to say hello to our team! 👋 Read their bios and view contact info here: https://t.co/YDz9qvDMgk #JPM2026

AI is no longer the barrier in drug development—readiness is. Read how @thermofisher - one of our partners for last month's R&D Reimagined event, built the foundation to scale meaningful, enterprise-level AI: https://t.co/feI8QbuBS4 #RDReimagined #PatientDriven

Thank you to all of our #MassBioMembers who came out to celebrate at our Annual Holiday Mixer, and to our sponsors for their continued support! ✨View all event photos✨ https://t.co/PR30OAw8N9

Don’t miss our upcoming webinar: Do More With Less – Boost Lab Productivity Through Smarter Equipment! 📅 Dec 11, 2025 | 11:00 AM ET Register now: https://t.co/6rkkRf24Sa

Thank you again to @MassBio for hosting our R&D Day! Opportunities to connect with members from the #oncology and #neurology ecosystem in Boston, and to share our approach with them, are invaluable. You can find a summary and link to the full session here: https://t.co/WdhwRD9QXT

The #DriveLifeSciences application for emerging biotech and biomarker/diagnostic companies is now live! MassBio and @SCBiotech are seeking applicants for the Spring program. Learn more & apply by 1/16 https://t.co/7L7tZHzGEa

Ann-Margaret Ferrante - our 2022 @MassBio Legislator of the Year - was the perfect storm: a state legislator who became a patient advocate, and a patient advocate who never stopped legislating. Read my full remembrance of Rep. Ferrante on LinkedIn: https://t.co/sANfUbj5Up.

We're looking back at the incredible #PatientAdvocacySummit25 - whether you were there with us or want to see what you missed, we invite you to watch every inspiring and motivating minute. Full sessions now available on #MBVision: https://t.co/FRKNv1W19r #PatientDriven

At last month's #AlignSummit25 Greg Graves of @McKinsey spoke about the potential impact AI will have on biopharma and innovation. Watch the full video on #MBVision - https://t.co/6YYb9PcgRZ Learn more about Align Summit: https://t.co/bBCk5EJ0jU

Thank you to legislators & others for attending, and to our speakers for sharing your insights. View all event photos: https://t.co/taSWyGq5xj #PatientDriven

It was a wide-ranging conversation about women's brain health, advancements in treatments, the importance of biomarker testing, and the painful realities of the disease for patients, families, and caregivers.

On Tuesday, MassBio partnered with the @MAWomensCaucus to host a symposium about women's health, with a focus on Alzheimer's disease across a woman's lifespan. Nearly 7 million Americans age 65 and older are living with Alzheimer's right now. Almost two-thirds of them are women.

Do More With Less in the Lab Join MassBio, @fishersci, and @HeidolphNA for a webinar on how smart, multifunctional equipment is reshaping research + QA workflows — and helping labs work smarter, not harder. 📅 Dec 11 | 11 AM ET 🔗 Register: https://t.co/6rkkRf2CHI

We're partnering with @Catalent_ to host #RDReimagined, and Global VP Karunakar Sukuru writes, "When a patient with diabetes, acromegaly, or a rare disease can swallow a capsule instead of facing a needle, everything improves..." - Read the blog: